You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 80 No. 1, JULY 1947 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

THIOURACILS AND THIOUREAS

Comparisons of the Absorption, Distribution, Destruction and Excretion

ROBERT H. WILLIAMS, M.D.; GLORIA A. KAY, B.S.

Arch Intern Med. 1947;80(1):37-52.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IN THE ATTEMPT to obtain antithyroid compounds which were superior to 2-thiouracil, it seemed important not only to test the thyroid-inhibiting effects of many related substances in animals1 but also to compare the activities of the more potent goitrogenic compounds in patients with thyrotoxicosis.2 Moreover, it was regarded as important to investigate the differences in the manner in which the body handles these drugs, especially as regards their absorption, distribution, destruction and excretion. Studies of this nature have previously been made with thiouracil,3 thiourea,4 diethylthiourea,2c tetramethylthiourea2c and aminothiazole.2g All these drugs are rapidly absorbed from the gastrointestinal tract and destroyed in the body. None of the first four compounds is excreted in the stools; approximately one third of these substances is excreted in the urine. In the case of thiouracil, which has been studied more extensively than the other compounds, the following significant observations have been . . . [Full Text PDF of this Article]


Author Affiliations

BOSTON

From the Thorndike Memorial Laboratory, Second and Fourth Medical Services (Harvard), Boston City Hospital, and the Department of Medicine, Harvard Medical School.


Footnotes

Most of the compounds used in this study were supplied by Mr. W. A. Lott, of the Squibb Institute, New Brunswick, N. J. Dr. R. O. Roblin, American Cyanamid Company, Stamford, Conn., contributed the 6-ethylthiouracil and 6-aminothiouracil.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1947 American Medical Association. All Rights Reserved.